A Study of Atezolizumab Compared With a Single-Agent Chemotherapy in Treatment Na√Øve Participants With Locally Advanced or Recurrent or Metastatic Non-Small Cell Lung Cancer Who Are Deemed Unsuitable For Platinum-Doublet Chemotherapy